StreetInsider.com News Articles

Tenax Therapeutics (TENX) PT Raised at Piper Sandler: 'Here's Why Now Is The Time to Own'

Fri, 12 Jun 2026 08:20:56 -0400

(Updated - June 12, 2026 8:20 AM EDT)

Piper Sandler analyst Yasmeen Rahimi raised the price target on Tenax Therapeutics (NASDAQ: TENX) to $50.00 (from $20.00) while maintaining an Overweight rating.

The analyst commented: "With Ph3 LEVEL Coming in 3Q26, Here's Why Now Is The Time to Own & PT Update; As we imminently approach TNX-103's Ph3 LEVEL topline on-track for 3Q26 (potentially ~Aug/Sep, per our math), we notice some investors expressing hesitancy to own the stock as they do not want to take risk into this key binary. However, we believe now is an opportune time to buy as we think

Tenax Therapeutics (TENX) PT Raised at Piper Sandler: 'Here's Why Now Is The Time to Own'

Fri, 12 Jun 2026 08:20:56 -0400

(Updated - June 12, 2026 8:20 AM EDT)

Piper Sandler analyst Yasmeen Rahimi raised the price target on Tenax Therapeutics (NASDAQ: TENX) to $50.00 (from $20.00) while maintaining an Overweight rating.

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PRICE T ROWE ASSOCIATES INC /MD/

Fri, 05 Jun 2026 11:41:00 -0400

si-local-file:///var/storage/secattach/20260605/26609708.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PRICE T ROWE ASSOCIATES INC /MD/

Fri, 05 Jun 2026 11:41:00 -0400

si-local-file:///var/storage/secattach/20260605/26609708.html

Form 8-K TENAX THERAPEUTICS, INC. For: Jun 02

Thu, 04 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260604/26605745.html

Form 8-K TENAX THERAPEUTICS, INC. For: Jun 02

Thu, 04 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260604/26605745.html

Piper Sandler Sees Sees a 'compelling buying opportunity' in Tenax Therapeutics (TENX)

Mon, 01 Jun 2026 08:06:30 -0400

Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $20.00 price target on Tenax Therapeutics (NASDAQ: TENX).

The analyst commented: "We hosted TENX mgmt on the road for productive investor meetings in Boston and NYC as we head into TNX-103's highly anticipated 12-week Ph3 LEVEL PH-HFpEF topline in 3Q26. Speaking with mgmt, we walk away with continued strong conviction for PoS, where the bogey is to establish any stat sig separation vs placebo on the 6MWD primary endpoints given nothing else approved for these patients. We believe LEVEL is de-risked to drive substantial share-gains, where a positive readout should also

Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: MILLENNIUM MANAGEMENT LLC

Wed, 20 May 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260520/26529422.html

Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: MILLENNIUM MANAGEMENT LLC

Wed, 20 May 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260520/26529422.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Logos Global Management LP

Fri, 15 May 2026 18:56:00 -0400

si-local-file:///var/storage/secattach/20260515/26508318.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Logos Global Management LP

Fri, 15 May 2026 18:56:00 -0400

si-local-file:///var/storage/secattach/20260515/26508318.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Stonepine Capital Management, LLC

Fri, 15 May 2026 17:29:00 -0400

si-local-file:///var/storage/secattach/20260515/26508009.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Stonepine Capital Management, LLC

Fri, 15 May 2026 17:29:00 -0400

si-local-file:///var/storage/secattach/20260515/26508009.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Venrock Healthcare Capital Partners III, L.P.

Fri, 15 May 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260515/26506824.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Venrock Healthcare Capital Partners III, L.P.

Fri, 15 May 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260515/26506824.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Point72 Asset Management, L.P.

Fri, 15 May 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260515/26506560.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Point72 Asset Management, L.P.

Fri, 15 May 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260515/26506560.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: BIOTECHNOLOGY VALUE FUND L P

Fri, 15 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260515/26505737.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: BIOTECHNOLOGY VALUE FUND L P

Fri, 15 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260515/26505737.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Lind Global Fund II LP

Fri, 15 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260515/26505763.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Lind Global Fund II LP

Fri, 15 May 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260515/26505763.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PERCEPTIVE ADVISORS LLC

Fri, 15 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260515/26504586.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PERCEPTIVE ADVISORS LLC

Fri, 15 May 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260515/26504586.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Dellora Investments LP

Fri, 15 May 2026 10:36:00 -0400

si-local-file:///var/storage/secattach/20260515/26501659.html

Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Dellora Investments LP

Fri, 15 May 2026 10:36:00 -0400

si-local-file:///var/storage/secattach/20260515/26501659.html